| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | TPO BMP1 DCHS2 FAT2 NOTCH2NLB FAT3 SLIT1 NOTCH2NLA CUBN NOTCH2NLC NOTCH1 NOTCH2 NOTCH3 CRB1 | 3.84e-07 | 749 | 72 | 14 | GO:0005509 |
| GeneOntologyMolecularFunction | Notch binding | 1.24e-04 | 27 | 72 | 3 | GO:0005112 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | KCNA5 NOTCH2NLB NOTCH2NLA SREBF2 NOTCH2NLC NOTCH1 NOTCH2 NOTCH3 | 8.56e-07 | 210 | 74 | 8 | GO:0007219 |
| GeneOntologyBiologicalProcess | neuron development | FLNA RIPOR2 HOXD9 PTPRK PLXNC1 RRN3 FAT3 SLIT1 ITGA4 NYAP1 SDK1 NOTCH1 NOTCH2 NOTCH3 CYFIP2 CRB1 OTOG | 1.26e-05 | 1463 | 74 | 17 | GO:0048666 |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 3.46e-05 | 171 | 74 | 6 | GO:0048593 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 3.80e-05 | 3 | 74 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 3.91e-05 | 53 | 74 | 4 | GO:0045747 | |
| GeneOntologyBiologicalProcess | neuron projection development | FLNA RIPOR2 PTPRK PLXNC1 RRN3 FAT3 SLIT1 ITGA4 NYAP1 SDK1 NOTCH1 NOTCH2 NOTCH3 CYFIP2 OTOG | 4.27e-05 | 1285 | 74 | 15 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 5.61e-05 | 114 | 74 | 5 | GO:0008593 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 9.21e-05 | 204 | 74 | 6 | GO:0048592 | |
| GeneOntologyBiologicalProcess | retina layer formation | 9.63e-05 | 25 | 74 | 3 | GO:0010842 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | FLNA DCHS2 FAT2 RIPOR2 ADAM19 IDO1 TRO FAT3 ITGA4 SDK1 NOTCH1 CYFIP2 CRB1 | 1.07e-04 | 1077 | 74 | 13 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.31e-04 | 313 | 74 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | BMP1 FLNA RIPOR2 RNLS HOXD9 ADAMTS9 FAT3 SLIT1 MUC19 SDK1 AHDC1 NOTCH1 NOTCH2 CRB1 | 1.46e-04 | 1269 | 74 | 14 | GO:0009887 |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 1.68e-04 | 30 | 74 | 3 | GO:0072012 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 1.85e-04 | 31 | 74 | 3 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 1.85e-04 | 31 | 74 | 3 | GO:0061437 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 1.89e-04 | 6 | 74 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 1.89e-04 | 6 | 74 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 2.29e-04 | 343 | 74 | 7 | GO:0090596 | |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 2.64e-04 | 7 | 74 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 2.64e-04 | 7 | 74 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | membrane repolarization during atrial cardiac muscle cell action potential | 2.64e-04 | 7 | 74 | 2 | GO:0098914 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | FLNA RIPOR2 PLXNC1 FAT3 SLIT1 ITGA4 NYAP1 ST14 NOTCH1 NOTCH2 NOTCH3 CYFIP2 CRB1 | 2.96e-04 | 1194 | 74 | 13 | GO:0000902 |
| GeneOntologyBiologicalProcess | retina morphogenesis in camera-type eye | 3.09e-04 | 90 | 74 | 4 | GO:0060042 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell membrane repolarization | 3.51e-04 | 8 | 74 | 2 | GO:0060372 | |
| GeneOntologyBiologicalProcess | atrioventricular node development | 4.50e-04 | 9 | 74 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | neural retina development | 4.97e-04 | 102 | 74 | 4 | GO:0003407 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 5.64e-04 | 187 | 74 | 5 | GO:0007156 | |
| GeneOntologyCellularComponent | cell surface | TPO DPP6 ADAM19 KCNA5 PTPRK ADAMTS9 ITGA4 CUBN ST14 NOTCH1 CD163 NOTCH2 NOTCH3 | 1.11e-04 | 1111 | 73 | 13 | GO:0009986 |
| GeneOntologyCellularComponent | receptor complex | 1.85e-04 | 581 | 73 | 9 | GO:0043235 | |
| GeneOntologyCellularComponent | apical plasma membrane | 2.92e-04 | 487 | 73 | 8 | GO:0016324 | |
| GeneOntologyCellularComponent | cell-cell junction | 1.04e-03 | 591 | 73 | 8 | GO:0005911 | |
| GeneOntologyCellularComponent | apical part of cell | 1.05e-03 | 592 | 73 | 8 | GO:0045177 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.10e-03 | 223 | 73 | 5 | GO:0098862 | |
| MousePheno | abnormal heart valve morphology | 5.92e-06 | 163 | 60 | 7 | MP:0000285 | |
| MousePheno | abnormal aortic valve cusp morphology | 4.76e-05 | 47 | 60 | 4 | MP:0010595 | |
| Domain | EGF_CA | TPO BMP1 FAT2 FAT3 SLIT1 NOTCH2NLA CUBN NOTCH2NLC NOTCH1 NOTCH2 NOTCH3 CRB1 | 3.21e-14 | 122 | 71 | 12 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | TPO BMP1 FAT2 FAT3 SLIT1 NOTCH2NLA CUBN NOTCH2NLC NOTCH1 NOTCH2 NOTCH3 CRB1 | 3.92e-14 | 124 | 71 | 12 | IPR001881 |
| Domain | EGF_Ca-bd_CS | TPO BMP1 FAT3 SLIT1 NOTCH2NLA CUBN NOTCH2NLC NOTCH1 NOTCH2 NOTCH3 CRB1 | 8.20e-14 | 97 | 71 | 11 | IPR018097 |
| Domain | EGF_CA | TPO BMP1 FAT3 SLIT1 NOTCH2NLA CUBN NOTCH2NLC NOTCH1 NOTCH2 NOTCH3 CRB1 | 1.03e-13 | 99 | 71 | 11 | PS01187 |
| Domain | EGF_3 | TPO BMP1 FAT2 ADAM19 FAT3 SLIT1 NOTCH2NLA CUBN NOTCH2NLC NOTCH1 NOTCH2 NOTCH3 CRB1 OTOG | 2.16e-13 | 235 | 71 | 14 | PS50026 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | TPO BMP1 FAT3 SLIT1 NOTCH2NLA CUBN NOTCH2NLC NOTCH1 NOTCH2 NOTCH3 CRB1 | 2.23e-13 | 106 | 71 | 11 | IPR000152 |
| Domain | EGF-like_dom | TPO BMP1 FAT2 ADAM19 FAT3 SLIT1 NOTCH2NLA CUBN NOTCH2NLC NOTCH1 NOTCH2 NOTCH3 CRB1 OTOG | 4.76e-13 | 249 | 71 | 14 | IPR000742 |
| Domain | ASX_HYDROXYL | TPO BMP1 FAT3 NOTCH2NLA CUBN NOTCH2NLC NOTCH1 NOTCH2 NOTCH3 CRB1 | 4.31e-12 | 100 | 71 | 10 | PS00010 |
| Domain | EGF_1 | TPO BMP1 FAT2 ADAM19 FAT3 SLIT1 NOTCH2NLA CUBN NOTCH2NLC NOTCH1 NOTCH2 NOTCH3 CRB1 | 1.21e-11 | 255 | 71 | 13 | PS00022 |
| Domain | EGF-like_CS | TPO BMP1 FAT2 ADAM19 FAT3 SLIT1 NOTCH2NLA CUBN NOTCH2NLC NOTCH1 NOTCH2 NOTCH3 CRB1 | 1.63e-11 | 261 | 71 | 13 | IPR013032 |
| Domain | EGF_2 | TPO BMP1 FAT2 ADAM19 FAT3 SLIT1 NOTCH2NLA CUBN NOTCH2NLC NOTCH1 NOTCH2 NOTCH3 CRB1 | 1.97e-11 | 265 | 71 | 13 | PS01186 |
| Domain | EGF_CA | 3.58e-11 | 86 | 71 | 9 | PF07645 | |
| Domain | EGF | BMP1 FAT2 SLIT1 NOTCH2NLA CUBN NOTCH2NLC NOTCH1 NOTCH2 NOTCH3 CRB1 | 4.43e-11 | 126 | 71 | 10 | PF00008 |
| Domain | EGF | TPO BMP1 FAT2 FAT3 SLIT1 NOTCH2NLA CUBN NOTCH2NLC NOTCH1 NOTCH2 NOTCH3 CRB1 | 7.91e-11 | 235 | 71 | 12 | SM00181 |
| Domain | DUF3454 | 5.26e-08 | 3 | 71 | 3 | PF11936 | |
| Domain | DUF3454_notch | 5.26e-08 | 3 | 71 | 3 | IPR024600 | |
| Domain | DUF3454 | 5.26e-08 | 3 | 71 | 3 | SM01334 | |
| Domain | hEGF | 6.32e-08 | 28 | 71 | 5 | PF12661 | |
| Domain | Growth_fac_rcpt_ | 1.35e-07 | 156 | 71 | 8 | IPR009030 | |
| Domain | Notch | 2.10e-07 | 4 | 71 | 3 | IPR008297 | |
| Domain | NODP | 2.10e-07 | 4 | 71 | 3 | PF07684 | |
| Domain | Notch_NODP_dom | 2.10e-07 | 4 | 71 | 3 | IPR011656 | |
| Domain | Notch_NOD_dom | 2.10e-07 | 4 | 71 | 3 | IPR010660 | |
| Domain | NOD | 2.10e-07 | 4 | 71 | 3 | PF06816 | |
| Domain | NOD | 2.10e-07 | 4 | 71 | 3 | SM01338 | |
| Domain | NODP | 2.10e-07 | 4 | 71 | 3 | SM01339 | |
| Domain | PHR | 5.24e-07 | 5 | 71 | 3 | PF08005 | |
| Domain | PHR | 5.24e-07 | 5 | 71 | 3 | IPR012983 | |
| Domain | LNR | 5.24e-07 | 5 | 71 | 3 | PS50258 | |
| Domain | CT | 1.33e-06 | 22 | 71 | 4 | SM00041 | |
| Domain | Notch_dom | 1.82e-06 | 7 | 71 | 3 | IPR000800 | |
| Domain | Notch | 1.82e-06 | 7 | 71 | 3 | PF00066 | |
| Domain | NL | 1.82e-06 | 7 | 71 | 3 | SM00004 | |
| Domain | Cys_knot_C | 2.28e-06 | 25 | 71 | 4 | IPR006207 | |
| Domain | CTCK_2 | 2.28e-06 | 25 | 71 | 4 | PS01225 | |
| Domain | TIL | 1.13e-05 | 12 | 71 | 3 | PF01826 | |
| Domain | C8 | 1.13e-05 | 12 | 71 | 3 | PF08742 | |
| Domain | LAM_G_DOMAIN | 1.28e-05 | 38 | 71 | 4 | PS50025 | |
| Domain | Unchr_dom_Cys-rich | 1.47e-05 | 13 | 71 | 3 | IPR014853 | |
| Domain | C8 | 1.47e-05 | 13 | 71 | 3 | SM00832 | |
| Domain | Laminin_G_2 | 1.58e-05 | 40 | 71 | 4 | PF02210 | |
| Domain | TIL_dom | 1.86e-05 | 14 | 71 | 3 | IPR002919 | |
| Domain | LamG | 2.32e-05 | 44 | 71 | 4 | SM00282 | |
| Domain | VWD | 2.85e-05 | 16 | 71 | 3 | SM00216 | |
| Domain | VWF_type-D | 2.85e-05 | 16 | 71 | 3 | IPR001846 | |
| Domain | VWFD | 2.85e-05 | 16 | 71 | 3 | PS51233 | |
| Domain | VWD | 2.85e-05 | 16 | 71 | 3 | PF00094 | |
| Domain | VWC_out | 4.88e-05 | 19 | 71 | 3 | SM00215 | |
| Domain | Laminin_G | 6.97e-05 | 58 | 71 | 4 | IPR001791 | |
| Domain | - | 4.70e-04 | 95 | 71 | 4 | 2.60.120.200 | |
| Domain | ZINC_PROTEASE | 5.29e-04 | 98 | 71 | 4 | PS00142 | |
| Domain | VWF_dom | 5.43e-04 | 42 | 71 | 3 | IPR001007 | |
| Domain | BTB | 6.12e-04 | 180 | 71 | 5 | SM00225 | |
| Domain | BTB/POZ_dom | 6.93e-04 | 185 | 71 | 5 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 7.63e-04 | 189 | 71 | 5 | IPR011333 | |
| Domain | CUB | 8.56e-04 | 49 | 71 | 3 | PF00431 | |
| Domain | CUB | 9.08e-04 | 50 | 71 | 3 | SM00042 | |
| Domain | - | 1.02e-03 | 52 | 71 | 3 | 2.60.120.290 | |
| Domain | CUB | 1.08e-03 | 53 | 71 | 3 | PS01180 | |
| Domain | CUB_dom | 1.33e-03 | 57 | 71 | 3 | IPR000859 | |
| Domain | ConA-like_dom | 1.47e-03 | 219 | 71 | 5 | IPR013320 | |
| Domain | BACK | 1.54e-03 | 60 | 71 | 3 | SM00875 | |
| Domain | EGF_extracell | 1.54e-03 | 60 | 71 | 3 | IPR013111 | |
| Domain | EGF_2 | 1.54e-03 | 60 | 71 | 3 | PF07974 | |
| Domain | BACK | 1.62e-03 | 61 | 71 | 3 | PF07707 | |
| Domain | BACK | 1.62e-03 | 61 | 71 | 3 | IPR011705 | |
| Domain | - | 1.66e-03 | 333 | 71 | 6 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.71e-03 | 335 | 71 | 6 | IPR015943 | |
| Domain | CTCK_1 | 2.10e-03 | 18 | 71 | 2 | PS01185 | |
| Domain | RCC1 | 2.59e-03 | 20 | 71 | 2 | PF00415 | |
| Domain | RCC1_1 | 2.86e-03 | 21 | 71 | 2 | PS00625 | |
| Domain | RCC1_2 | 2.86e-03 | 21 | 71 | 2 | PS00626 | |
| Domain | RCC1_3 | 2.86e-03 | 21 | 71 | 2 | PS50012 | |
| Domain | Reg_chr_condens | 3.13e-03 | 22 | 71 | 2 | IPR000408 | |
| Domain | - | 3.13e-03 | 22 | 71 | 2 | 2.130.10.30 | |
| Domain | BTB | 3.23e-03 | 160 | 71 | 4 | PS50097 | |
| Domain | RCC1/BLIP-II | 3.42e-03 | 23 | 71 | 2 | IPR009091 | |
| Domain | MetalloPept_cat_dom | 3.63e-03 | 81 | 71 | 3 | IPR024079 | |
| Domain | - | 3.63e-03 | 81 | 71 | 3 | 3.40.390.10 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 6.57e-07 | 5 | 58 | 3 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 1.31e-06 | 6 | 58 | 3 | M27068 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 8.46e-06 | 68 | 58 | 5 | M27303 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.07e-05 | 11 | 58 | 3 | M47865 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.42e-05 | 12 | 58 | 3 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.42e-05 | 12 | 58 | 3 | M47533 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.84e-05 | 13 | 58 | 3 | M47423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.84e-05 | 13 | 58 | 3 | M47534 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 5.16e-05 | 18 | 58 | 3 | M614 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 1.26e-04 | 24 | 58 | 3 | M11190 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.65e-04 | 5 | 58 | 2 | MM14733 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.80e-04 | 27 | 58 | 3 | M39545 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.01e-04 | 28 | 58 | 3 | M6177 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.98e-04 | 143 | 58 | 5 | M27275 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 3.45e-04 | 7 | 58 | 2 | MM14734 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 3.61e-04 | 34 | 58 | 3 | M39390 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.29e-04 | 36 | 58 | 3 | M27245 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 5.48e-04 | 250 | 58 | 6 | M27554 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 8.30e-04 | 45 | 58 | 3 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 8.85e-04 | 46 | 58 | 3 | MM15971 | |
| Pathway | BIOCARTA_NPC_PATHWAY | 8.93e-04 | 11 | 58 | 2 | M22033 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 9.42e-04 | 47 | 58 | 3 | M7946 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.07e-03 | 12 | 58 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.07e-03 | 12 | 58 | 2 | M22042 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.34e-03 | 53 | 58 | 3 | M27212 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.49e-03 | 55 | 58 | 3 | MM14917 | |
| Pubmed | Evolution of Human Brain Size-Associated NOTCH2NL Genes Proceeds toward Reduced Protein Levels. | 1.99e-11 | 4 | 75 | 4 | 32330268 | |
| Pubmed | Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis. | 9.95e-11 | 5 | 75 | 4 | 29856954 | |
| Pubmed | 9.63e-09 | 3 | 75 | 3 | 7615640 | ||
| Pubmed | 9.63e-09 | 3 | 75 | 3 | 7918097 | ||
| Pubmed | 9.63e-09 | 3 | 75 | 3 | 8645602 | ||
| Pubmed | Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study. | 9.63e-09 | 3 | 75 | 3 | 21471519 | |
| Pubmed | 9.63e-09 | 3 | 75 | 3 | 27697639 | ||
| Pubmed | Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease. | 9.63e-09 | 3 | 75 | 3 | 29767458 | |
| Pubmed | 9.63e-09 | 3 | 75 | 3 | 7698746 | ||
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 3.85e-08 | 4 | 75 | 3 | 28061457 | |
| Pubmed | 3.85e-08 | 4 | 75 | 3 | 24145721 | ||
| Pubmed | 3.85e-08 | 4 | 75 | 3 | 20069356 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 3.85e-08 | 4 | 75 | 3 | 19404845 | |
| Pubmed | 3.85e-08 | 4 | 75 | 3 | 28669409 | ||
| Pubmed | 3.85e-08 | 4 | 75 | 3 | 29561261 | ||
| Pubmed | 3.85e-08 | 4 | 75 | 3 | 10551863 | ||
| Pubmed | 3.85e-08 | 4 | 75 | 3 | 11466531 | ||
| Pubmed | 3.85e-08 | 4 | 75 | 3 | 24151014 | ||
| Pubmed | 3.85e-08 | 4 | 75 | 3 | 11401408 | ||
| Pubmed | Novel MIR143-NOTCH fusions in benign and malignant glomus tumors. | 3.85e-08 | 4 | 75 | 3 | 23999936 | |
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 3.85e-08 | 4 | 75 | 3 | 10194420 | |
| Pubmed | 3.85e-08 | 4 | 75 | 3 | 18156632 | ||
| Pubmed | Functional conservation of mouse Notch receptor family members. | 3.85e-08 | 4 | 75 | 3 | 8898100 | |
| Pubmed | 3.85e-08 | 4 | 75 | 3 | 11978185 | ||
| Pubmed | 3.85e-08 | 4 | 75 | 3 | 11459941 | ||
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 3.85e-08 | 4 | 75 | 3 | 18184405 | |
| Pubmed | Notch signaling in the mammalian central nervous system: insights from mouse mutants. | 3.85e-08 | 4 | 75 | 3 | 15917835 | |
| Pubmed | 3.85e-08 | 4 | 75 | 3 | 23444212 | ||
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 3.85e-08 | 4 | 75 | 3 | 17920003 | |
| Pubmed | Notch signaling in bulge stem cells is not required for selection of hair follicle fate. | 9.60e-08 | 5 | 75 | 3 | 19211676 | |
| Pubmed | Human-Specific NOTCH2NL Genes Expand Cortical Neurogenesis through Delta/Notch Regulation. | 9.60e-08 | 5 | 75 | 3 | 29856955 | |
| Pubmed | 9.60e-08 | 5 | 75 | 3 | 27040987 | ||
| Pubmed | 9.60e-08 | 5 | 75 | 3 | 21124806 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 9.60e-08 | 5 | 75 | 3 | 15064243 | |
| Pubmed | A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. | 9.60e-08 | 5 | 75 | 3 | 21562564 | |
| Pubmed | 9.60e-08 | 5 | 75 | 3 | 23675950 | ||
| Pubmed | 9.60e-08 | 5 | 75 | 3 | 11101851 | ||
| Pubmed | 9.60e-08 | 5 | 75 | 3 | 15076712 | ||
| Pubmed | 9.60e-08 | 5 | 75 | 3 | 12242712 | ||
| Pubmed | 9.60e-08 | 5 | 75 | 3 | 15882997 | ||
| Pubmed | 1.92e-07 | 6 | 75 | 3 | 9111338 | ||
| Pubmed | 1.92e-07 | 6 | 75 | 3 | 20870902 | ||
| Pubmed | 1.92e-07 | 6 | 75 | 3 | 26062937 | ||
| Pubmed | ALDH maintains the stemness of lung adenoma stem cells by suppressing the Notch/CDK2/CCNE pathway. | 1.92e-07 | 6 | 75 | 3 | 24671051 | |
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 1.92e-07 | 6 | 75 | 3 | 12244553 | |
| Pubmed | 1.92e-07 | 6 | 75 | 3 | 22526456 | ||
| Pubmed | 1.92e-07 | 6 | 75 | 3 | 19503073 | ||
| Pubmed | Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. | 1.92e-07 | 6 | 75 | 3 | 19573812 | |
| Pubmed | Expression of Deltex1 during mouse embryogenesis: comparison with Notch1, 2 and 3 expression. | 1.92e-07 | 6 | 75 | 3 | 11731257 | |
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 1.92e-07 | 6 | 75 | 3 | 19603167 | |
| Pubmed | 1.92e-07 | 6 | 75 | 3 | 18299578 | ||
| Pubmed | 1.92e-07 | 6 | 75 | 3 | 9108364 | ||
| Pubmed | 1.92e-07 | 6 | 75 | 3 | 9882480 | ||
| Pubmed | Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene. | 1.92e-07 | 6 | 75 | 3 | 15019995 | |
| Pubmed | Notch controls the magnitude of T helper cell responses by promoting cellular longevity. | 1.92e-07 | 6 | 75 | 3 | 22615412 | |
| Pubmed | Notch lineages and activity in intestinal stem cells determined by a new set of knock-in mice. | 1.92e-07 | 6 | 75 | 3 | 21991352 | |
| Pubmed | 1.92e-07 | 6 | 75 | 3 | 27460529 | ||
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 10383933 | ||
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 3.35e-07 | 7 | 75 | 3 | 12846471 | |
| Pubmed | Murine notch homologs (N1-4) undergo presenilin-dependent proteolysis. | 3.35e-07 | 7 | 75 | 3 | 11518718 | |
| Pubmed | Differentiation of CD11c+ CX3CR1+ cells in the small intestine requires Notch signaling. | 3.35e-07 | 7 | 75 | 3 | 24711412 | |
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 16059920 | ||
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 16169548 | ||
| Pubmed | 5.35e-07 | 8 | 75 | 3 | 22156581 | ||
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 5.35e-07 | 8 | 75 | 3 | 22652674 | |
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 5.35e-07 | 8 | 75 | 3 | 12242716 | |
| Pubmed | Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. | 5.35e-07 | 8 | 75 | 3 | 15465493 | |
| Pubmed | 5.35e-07 | 8 | 75 | 3 | 9858718 | ||
| Pubmed | 5.35e-07 | 8 | 75 | 3 | 11044610 | ||
| Pubmed | Essential roles of Meltrin beta (ADAM19) in heart development. | 5.35e-07 | 8 | 75 | 3 | 14975714 | |
| Pubmed | 6.00e-07 | 31 | 75 | 4 | 22274697 | ||
| Pubmed | 8.02e-07 | 9 | 75 | 3 | 11118901 | ||
| Pubmed | 8.02e-07 | 9 | 75 | 3 | 16245338 | ||
| Pubmed | 8.02e-07 | 9 | 75 | 3 | 12370315 | ||
| Pubmed | 8.02e-07 | 9 | 75 | 3 | 17573339 | ||
| Pubmed | 8.02e-07 | 9 | 75 | 3 | 18507503 | ||
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 9.93e-07 | 35 | 75 | 4 | 21252157 | |
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 1.14e-06 | 10 | 75 | 3 | 23665443 | |
| Pubmed | Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer. | 1.14e-06 | 10 | 75 | 3 | 28489825 | |
| Pubmed | 1.14e-06 | 10 | 75 | 3 | 15525534 | ||
| Pubmed | 1.14e-06 | 10 | 75 | 3 | 24015274 | ||
| Pubmed | 1.14e-06 | 10 | 75 | 3 | 33915108 | ||
| Pubmed | 1.31e-06 | 87 | 75 | 5 | 37495603 | ||
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 1.57e-06 | 11 | 75 | 3 | 16607638 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 1.57e-06 | 11 | 75 | 3 | 15499562 | |
| Pubmed | 1.57e-06 | 11 | 75 | 3 | 10878608 | ||
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 1.57e-06 | 11 | 75 | 3 | 9187150 | |
| Pubmed | 1.57e-06 | 11 | 75 | 3 | 12866128 | ||
| Pubmed | 2.09e-06 | 12 | 75 | 3 | 10952889 | ||
| Pubmed | 2.09e-06 | 12 | 75 | 3 | 15465494 | ||
| Pubmed | 2.09e-06 | 12 | 75 | 3 | 32147304 | ||
| Pubmed | 2.09e-06 | 12 | 75 | 3 | 14732396 | ||
| Pubmed | A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. | 2.71e-06 | 13 | 75 | 3 | 32929274 | |
| Pubmed | Notch signaling coordinates the patterning of striatal compartments. | 2.71e-06 | 13 | 75 | 3 | 16120638 | |
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 2.71e-06 | 13 | 75 | 3 | 31202705 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 2.71e-06 | 13 | 75 | 3 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 2.71e-06 | 13 | 75 | 3 | 20558824 | |
| Pubmed | 2.71e-06 | 13 | 75 | 3 | 23132245 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 3.34e-06 | 560 | 75 | 9 | 21653829 | |
| Interaction | CASR interactions | 1.10e-06 | 22 | 73 | 4 | int:CASR | |
| Interaction | LGALS1 interactions | 3.08e-06 | 332 | 73 | 9 | int:LGALS1 | |
| Interaction | DYRK1A interactions | RALGAPA1 DCHS2 ERBB3 ADAM19 WDHD1 ADAMTS9 TSPYL2 ICE1 NUP214 NUP153 NOTCH2 | 4.51e-06 | 552 | 73 | 11 | int:DYRK1A |
| Interaction | IGSF5 interactions | 1.61e-05 | 14 | 73 | 3 | int:IGSF5 | |
| Interaction | ELSPBP1 interactions | 2.09e-05 | 92 | 73 | 5 | int:ELSPBP1 | |
| Interaction | MAML2 interactions | 2.99e-05 | 17 | 73 | 3 | int:MAML2 | |
| Interaction | EDN3 interactions | 4.53e-05 | 108 | 73 | 5 | int:EDN3 | |
| Interaction | MAML3 interactions | 4.97e-05 | 20 | 73 | 3 | int:MAML3 | |
| Interaction | DTX4 interactions | 6.68e-05 | 22 | 73 | 3 | int:DTX4 | |
| Interaction | NTN5 interactions | 8.74e-05 | 24 | 73 | 3 | int:NTN5 | |
| Interaction | CFC1 interactions | 9.43e-05 | 126 | 73 | 5 | int:CFC1 | |
| Interaction | HBA1 interactions | 1.02e-04 | 67 | 73 | 4 | int:HBA1 | |
| Interaction | PPP1R12B interactions | 1.08e-04 | 68 | 73 | 4 | int:PPP1R12B | |
| Interaction | FBXO2 interactions | 1.18e-04 | 411 | 73 | 8 | int:FBXO2 | |
| Interaction | MTNR1B interactions | 1.31e-04 | 135 | 73 | 5 | int:MTNR1B | |
| Interaction | EGFL7 interactions | 1.76e-04 | 77 | 73 | 4 | int:EGFL7 | |
| Interaction | CST9L interactions | 1.85e-04 | 78 | 73 | 4 | int:CST9L | |
| Interaction | TMEM108 interactions | 1.91e-04 | 31 | 73 | 3 | int:TMEM108 | |
| Interaction | ADAMTS9 interactions | 1.92e-04 | 6 | 73 | 2 | int:ADAMTS9 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q33 | 9.77e-04 | 118 | 75 | 3 | chr5q33 | |
| Cytoband | 5q33.3 | 1.60e-03 | 36 | 75 | 2 | 5q33.3 | |
| GeneFamily | Cadherin related | 1.16e-05 | 17 | 48 | 3 | 24 | |
| GeneFamily | CD molecules|Mucins | 1.40e-03 | 21 | 48 | 2 | 648 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 3.44e-06 | 569 | 72 | 10 | M12701 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 9.48e-06 | 270 | 72 | 7 | M19432 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.08e-05 | 16 | 72 | 3 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.08e-05 | 16 | 72 | 3 | M2207 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 1.31e-05 | 284 | 72 | 7 | MM987 | |
| Coexpression | GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN | 1.83e-05 | 199 | 72 | 6 | M5206 | |
| Coexpression | GSE22886_DC_VS_MONOCYTE_DN | 1.88e-05 | 200 | 72 | 6 | M4472 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 FLNA RIPOR2 ADAM19 TSPYL2 ICE1 BTBD1 ITGA4 NEK9 TUBA4A NOTCH1 NUP153 NOTCH2 CYFIP2 | 4.69e-05 | 1492 | 72 | 14 | M40023 |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_DN | 5.22e-05 | 240 | 72 | 6 | M6413 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 5.27e-05 | 482 | 72 | 8 | M12144 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 5.59e-05 | 630 | 72 | 9 | MM1038 | |
| Coexpression | MCLACHLAN_DENTAL_CARIES_DN | 7.79e-05 | 82 | 72 | 4 | M1278 | |
| Coexpression | JAEGER_METASTASIS_DN | 8.12e-05 | 260 | 72 | 6 | M10702 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 9.06e-05 | 385 | 72 | 7 | M39264 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 9.31e-05 | 32 | 72 | 3 | M5903 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 1.01e-04 | 681 | 72 | 9 | M39175 | |
| Coexpression | GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN | 1.39e-04 | 180 | 72 | 5 | M6317 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 1.58e-04 | 185 | 72 | 5 | M42503 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 1.76e-04 | 574 | 72 | 8 | M39056 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.77e-04 | 300 | 72 | 6 | M8702 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 1.88e-04 | 192 | 72 | 5 | M42501 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 2.06e-04 | 8 | 72 | 2 | M9884 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_DN | 2.11e-04 | 42 | 72 | 3 | M8155 | |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP | 2.22e-04 | 199 | 72 | 5 | M8371 | |
| Coexpression | GSE27786_LSK_VS_BCELL_DN | 2.22e-04 | 199 | 72 | 5 | M4744 | |
| Coexpression | GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP | 2.27e-04 | 200 | 72 | 5 | M4672 | |
| Coexpression | GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP | 2.27e-04 | 200 | 72 | 5 | M3413 | |
| Coexpression | GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP | 2.27e-04 | 200 | 72 | 5 | M7283 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN | 2.27e-04 | 200 | 72 | 5 | M3893 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 2.38e-04 | 600 | 72 | 8 | M39055 | |
| Coexpression | RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN | 2.51e-04 | 320 | 72 | 6 | M8582 | |
| ToppCell | IPF-Lymphoid|IPF / Disease state, Lineage and Cell class | 3.72e-08 | 193 | 75 | 7 | bf9d50aea909a28dd1d0933af33842d5f1ae7818 | |
| ToppCell | Control-Lymphoid|Control / Disease state, Lineage and Cell class | 3.85e-08 | 194 | 75 | 7 | d5b124f15c953eeb7e8e990df44d7fa466f2b31f | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 6.24e-07 | 181 | 75 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 6.65e-07 | 183 | 75 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.65e-07 | 183 | 75 | 6 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 7.79e-07 | 188 | 75 | 6 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 8.28e-07 | 190 | 75 | 6 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | COPD-Lymphoid|COPD / Disease state, Lineage and Cell class | 8.80e-07 | 192 | 75 | 6 | 064fefb8212fadab0ff441f4bf643559b7fdb25d | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | 8.80e-07 | 192 | 75 | 6 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa | |
| ToppCell | Control-Lymphoid-T|Control / Disease state, Lineage and Cell class | 9.08e-07 | 193 | 75 | 6 | af928046ccd1ca874be1534aef6ca7f27d90bc46 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 9.08e-07 | 193 | 75 | 6 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.08e-07 | 193 | 75 | 6 | 9c9434a3297b85774b4f0ecab6294f44d738e29f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.93e-07 | 196 | 75 | 6 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | Mild_COVID-19-T/NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.05e-06 | 198 | 75 | 6 | 329eb0fc0bda3d66765de0393290dccb3e15c311 | |
| ToppCell | distal-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.08e-06 | 199 | 75 | 6 | 5e209df67cfe8ac7437cc363f1c5c3166bfae1af | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.08e-06 | 199 | 75 | 6 | f393f8d2b9711e71beb4f1c5e7cac5acb047fd0e | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.08e-06 | 199 | 75 | 6 | fa362f3e456a4853652e52d54e76473809eea76d | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-06 | 200 | 75 | 6 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.69e-06 | 151 | 75 | 5 | d19fc363ba1d7ff77e0adcaacafa4c64e1143f40 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.88e-06 | 157 | 75 | 5 | 5aee90ad7aaa65fdabc23597451da5e48db8f4e6 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.54e-06 | 160 | 75 | 5 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 7.77e-06 | 161 | 75 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.01e-06 | 162 | 75 | 5 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.56e-06 | 168 | 75 | 5 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-05 | 170 | 75 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-05 | 174 | 75 | 5 | d77fa525d5c87c190b4a10787b270eabd16c610f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-05 | 174 | 75 | 5 | 41eb0a214a8b4015a26311f77061c8147144f0e7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 174 | 75 | 5 | 1b2a2129c08bac01fc638692313b196759a1e0d7 | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 1.13e-05 | 174 | 75 | 5 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-05 | 174 | 75 | 5 | 5bde24eb588dc588efc413811379548120ec0c7f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-05 | 175 | 75 | 5 | 1d1928581a4df5f9e3398f9bf3334990e39f9851 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-05 | 177 | 75 | 5 | 921783ed0fe20294d2f384d9136924b679df01bb | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.23e-05 | 177 | 75 | 5 | 5cdf413f82376a95467322b16d10b0d1e7557e2d | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_Exhausted-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-05 | 177 | 75 | 5 | 28f2ea29a52de90301e6ba770f407ee4034936d5 | |
| ToppCell | Control-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 1.23e-05 | 177 | 75 | 5 | e82115bfc32c7b689460fbc5caeb983c1aabe30f | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_Exhausted|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-05 | 177 | 75 | 5 | f87bbc9403e909bb534eb705bcd2bca83d072cc7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-05 | 178 | 75 | 5 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 1.26e-05 | 178 | 75 | 5 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.30e-05 | 179 | 75 | 5 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-05 | 179 | 75 | 5 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | CTRL-Lymphoid-B_cell|CTRL / Disease state, Lineage and Cell class | 1.30e-05 | 179 | 75 | 5 | dd4055c0a8360ea10323ef6249519a6ae08fc05a | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 1.30e-05 | 179 | 75 | 5 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | COPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 1.30e-05 | 179 | 75 | 5 | 29b058c5e33fda9f0d738c074bdb67ff16b9b6d5 | |
| ToppCell | IPF-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 1.33e-05 | 180 | 75 | 5 | 0f8567aa835d4e3a52f6631ae15216eca18a030c | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.33e-05 | 180 | 75 | 5 | 38035cf2c6fbc443ea10ca7e942572715ed572da | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 1.33e-05 | 180 | 75 | 5 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-05 | 181 | 75 | 5 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.44e-05 | 183 | 75 | 5 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-05 | 183 | 75 | 5 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.48e-05 | 184 | 75 | 5 | 0a26bcc6610f756939e32a4d6dfeebcbf3a1db86 | |
| ToppCell | COVID-CD4-naive_CD4|COVID / Condition, Cell_class and T cell subcluster | 1.48e-05 | 184 | 75 | 5 | 00db55970d336a301035efe43a4ab4db62627f38 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-05 | 185 | 75 | 5 | fec16a5e527fdef32d25957451b6e8ee9796cafd | |
| ToppCell | proximal-3-Hematologic-Myeloid_Dendritic_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.56e-05 | 186 | 75 | 5 | c920dffd24f051b54d8b48f801fffc928d99e135 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.56e-05 | 186 | 75 | 5 | d740aca5dc4240851ba7bc5988c0970d785ad0c2 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.56e-05 | 186 | 75 | 5 | 4ca7f6c043874a0c536f75af5ca24c7c66725e54 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.64e-05 | 188 | 75 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 188 | 75 | 5 | 842982de2197770f999a70083ed9fca40ac22d79 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 188 | 75 | 5 | a0815eaf68eedd6e5ec4af520df80a6ab4eb0864 | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.64e-05 | 188 | 75 | 5 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | IPF-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 1.69e-05 | 189 | 75 | 5 | 49e67d298d045f29136919b7d9971b6502b0efaa | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8-Tem/emra_CD8|Lung / Manually curated celltypes from each tissue | 1.69e-05 | 189 | 75 | 5 | f43bb9db7bb2d19c9849cd3ed892fe3e09e7dfe2 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.69e-05 | 189 | 75 | 5 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.69e-05 | 189 | 75 | 5 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.73e-05 | 190 | 75 | 5 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.73e-05 | 190 | 75 | 5 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|IPF / Disease state, Lineage and Cell class | 1.73e-05 | 190 | 75 | 5 | e5d0186bfb416a3eda76ac12b9379650afb6f409 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 190 | 75 | 5 | e04f47705851563515b6a66a2634cf7a574f7bda | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 190 | 75 | 5 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 190 | 75 | 5 | 0bad41d19dc515e6bc61e699f4d56664cf2e72fd | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.77e-05 | 191 | 75 | 5 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | Adult-Immune-T_lymphocyte-D175|Adult / Lineage, Cell type, age group and donor | 1.77e-05 | 191 | 75 | 5 | 0b84fd1dc68146d9f72422b102744d2847f5ecb2 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-05 | 191 | 75 | 5 | 14851529025cfc2b665f71ebad04150ec543da7a | |
| ToppCell | Control-Lymphoid-T_Cytotoxic|Control / Disease state, Lineage and Cell class | 1.77e-05 | 191 | 75 | 5 | 03b5c5e0941c3402ab3f48cbf3da2a027d110421 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-05 | 191 | 75 | 5 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 1.77e-05 | 191 | 75 | 5 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-05 | 191 | 75 | 5 | e14b22e882ac92acf8c8b6ee997ef8e799c7a8d5 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 1.82e-05 | 192 | 75 | 5 | 5bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1 | |
| ToppCell | COPD-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 1.82e-05 | 192 | 75 | 5 | baebd462f464e7d0e462d07a74bb5d685a9fc3b6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 192 | 75 | 5 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | IPF-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 1.82e-05 | 192 | 75 | 5 | 9b06c7336624ef21f8e5393725b56038a8028e57 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 192 | 75 | 5 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | Healthy_Control-Lymphoid-T-CCR7+_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.82e-05 | 192 | 75 | 5 | 5b197f65a87c315e4f50c77a7fdec3b342a863ad | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.82e-05 | 192 | 75 | 5 | 189477c44040cf0ee16c3932fa49fbd9e3acaa3c | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-05 | 192 | 75 | 5 | a0bd4a0d00246af4f6645e66a0dedfe36882cc60 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8|Lung / Manually curated celltypes from each tissue | 1.82e-05 | 192 | 75 | 5 | f53426b9b1a63529307751c490a5a6214e499317 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|COPD / Disease state, Lineage and Cell class | 1.87e-05 | 193 | 75 | 5 | 58e94fe2e89cdafc6974938f97a4c162061a437d | |
| ToppCell | Adult-Immune-T_lymphocyte|Adult / Lineage, Cell type, age group and donor | 1.87e-05 | 193 | 75 | 5 | 26df0c4c8a2355dd5503fadd07e368eb9a2bf06a | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 1.87e-05 | 193 | 75 | 5 | 35c902a983d7f1156a74fe68ee366609029833b3 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.87e-05 | 193 | 75 | 5 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 194 | 75 | 5 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 194 | 75 | 5 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-05 | 194 | 75 | 5 | dfe0ece81922bfd7c6673726d3ea2365cbdb5513 | |
| ToppCell | Adult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.91e-05 | 194 | 75 | 5 | 5c1dca33f382f37a7deb23e573578343c3b54986 | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 1.91e-05 | 194 | 75 | 5 | 2a144a1c2d537c8a59aa419206ddd96c23f0aeab | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic|Lung / Manually curated celltypes from each tissue | 1.96e-05 | 195 | 75 | 5 | b748cb15846345363e8c2ee5936bb42bba3ba9a7 | |
| ToppCell | distal-Hematologic-Nonclassical_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.96e-05 | 195 | 75 | 5 | 6f417bb464b8ae6a50bbab5db5a6d5760c02122f | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.96e-05 | 195 | 75 | 5 | 6ddce0cce14f737e45b8f57802c6a8ad07686262 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.96e-05 | 195 | 75 | 5 | e6212373cc3c6c98f76e104e2ac1afa68965cc5f | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.96e-05 | 195 | 75 | 5 | ffb40486f8097b2c08e8f3b3685d0b8cb8d1bc66 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.96e-05 | 195 | 75 | 5 | b8124e8a23e6d37b40023608674e67285c6ffe84 | |
| Drug | 1-piperidinocyclohexanecarbonitrile | 1.17e-06 | 25 | 73 | 4 | CID000062529 | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; PC3; HT_HG-U133A | 3.17e-06 | 196 | 73 | 7 | 5771_UP | |
| Drug | Sulfadiazine [68-35-9]; Up 200; 16uM; PC3; HT_HG-U133A | 3.28e-06 | 197 | 73 | 7 | 5098_UP | |
| Drug | Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.39e-06 | 198 | 73 | 7 | 5988_UP | |
| Drug | methylthymol blue | 3.04e-05 | 3 | 73 | 2 | CID000073037 | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; PC3; HT_HG-U133A | 3.44e-05 | 191 | 73 | 6 | 4487_UP | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 3.86e-05 | 195 | 73 | 6 | 3710_DN | |
| Drug | Asiaticoside [16830-15-2]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 4.09e-05 | 197 | 73 | 6 | 3504_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.09e-05 | 197 | 73 | 6 | 3413_UP | |
| Drug | Equilin [474-86-2]; Up 200; 15uM; HL60; HT_HG-U133A | 4.09e-05 | 197 | 73 | 6 | 3039_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; HL60; HT_HG-U133A | 4.21e-05 | 198 | 73 | 6 | 2542_DN | |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; PC3; HT_HG-U133A | 4.21e-05 | 198 | 73 | 6 | 4669_DN | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 4.33e-05 | 199 | 73 | 6 | 3603_UP | |
| Drug | Linuron | 5.74e-05 | 128 | 73 | 5 | ctd:D008044 | |
| Drug | gamma-secretase inhibitor I | 6.06e-05 | 4 | 73 | 2 | CID011754711 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 4.44e-07 | 7 | 70 | 3 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 4.44e-07 | 7 | 70 | 3 | DOID:3620 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 9.93e-07 | 32 | 70 | 4 | DOID:10155 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | BMP1 FLNA ERBB3 KCNA5 IDO1 TFPI2 SREBF2 OXSM NUP214 CUBN NOTCH1 NOTCH2 NOTCH3 | 1.27e-06 | 1074 | 70 | 13 | C0006142 |
| Disease | Squamous cell carcinoma of esophagus | 3.19e-06 | 95 | 70 | 5 | C0279626 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 5.70e-06 | 15 | 70 | 3 | C0496930 | |
| Disease | Benign neoplasm of bladder | 5.70e-06 | 15 | 70 | 3 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 5.70e-06 | 15 | 70 | 3 | C0154091 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 7.12e-06 | 195 | 70 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Carcinoma of bladder | 1.02e-05 | 18 | 70 | 3 | C0699885 | |
| Disease | Malignant neoplasm of skin | 1.20e-05 | 59 | 70 | 4 | C0007114 | |
| Disease | Skin Neoplasms | 1.20e-05 | 59 | 70 | 4 | C0037286 | |
| Disease | obesity (implicated_via_orthology) | 1.24e-05 | 215 | 70 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | brain cancer (implicated_via_orthology) | 3.20e-05 | 26 | 70 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | 3.42e-05 | 525 | 70 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 3.42e-05 | 525 | 70 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 3.51e-05 | 527 | 70 | 8 | C1458155 | |
| Disease | Breast Carcinoma | 4.06e-05 | 538 | 70 | 8 | C0678222 | |
| Disease | colorectal cancer (implicated_via_orthology) | 4.96e-05 | 30 | 70 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | cortical thickness | TRMT9B STRN3 ERBB3 RIPOR2 KCNA5 RNLS ADAMTS9 PLXNC1 FAT3 BTBD1 PNKD | 5.89e-05 | 1113 | 70 | 11 | EFO_0004840 |
| Disease | T-cell immunoglobulin and mucin domain 1 measurement | 1.16e-04 | 7 | 70 | 2 | EFO_0010812 | |
| Disease | response to tamoxifen | 1.98e-04 | 9 | 70 | 2 | EFO_0009391 | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 2.12e-04 | 228 | 70 | 5 | EFO_0003948, MONDO_0004975 | |
| Disease | asthma | 3.98e-04 | 751 | 70 | 8 | MONDO_0004979 | |
| Disease | pre-eclampsia (implicated_via_orthology) | 4.25e-04 | 13 | 70 | 2 | DOID:10591 (implicated_via_orthology) | |
| Disease | psoriasis | 4.84e-04 | 273 | 70 | 5 | EFO_0000676 | |
| Disease | Crohn's disease | 6.30e-04 | 441 | 70 | 6 | EFO_0000384 | |
| Disease | vision disorder | 6.52e-04 | 16 | 70 | 2 | MONDO_0021084 | |
| Disease | inflammatory bowel disease | 6.92e-04 | 449 | 70 | 6 | EFO_0003767 | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 7.37e-04 | 17 | 70 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | disease free survival | 8.28e-04 | 18 | 70 | 2 | EFO_0000409 | |
| Disease | Glioblastoma | 8.89e-04 | 79 | 70 | 3 | C0017636 | |
| Disease | diet measurement, colorectal cancer | 9.24e-04 | 19 | 70 | 2 | EFO_0008111, MONDO_0005575 | |
| Disease | Giant Cell Glioblastoma | 1.06e-03 | 84 | 70 | 3 | C0334588 | |
| Disease | thalamus volume | 1.10e-03 | 85 | 70 | 3 | EFO_0006935 | |
| Disease | neuritic plaque measurement | 1.45e-03 | 349 | 70 | 5 | EFO_0006798 | |
| Disease | Carcinoma, Pancreatic Ductal | 1.48e-03 | 24 | 70 | 2 | C0887833 | |
| Disease | serum IgG glycosylation measurement | 1.51e-03 | 523 | 70 | 6 | EFO_0005193 | |
| Disease | Cerebral Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0334583 | |
| Disease | Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.61e-03 | 25 | 70 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 1.74e-03 | 26 | 70 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.74e-03 | 26 | 70 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.74e-03 | 26 | 70 | 2 | C0334582 | |
| Disease | Anaplastic astrocytoma | 1.87e-03 | 27 | 70 | 2 | C0334579 | |
| Disease | brain measurement, neuroimaging measurement | 1.95e-03 | 550 | 70 | 6 | EFO_0004346, EFO_0004464 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 2.10e-03 | 227 | 70 | 4 | EFO_0004346, EFO_0010736 | |
| Disease | Epileptic encephalopathy | 2.31e-03 | 30 | 70 | 2 | C0543888 | |
| Disease | Glioblastoma Multiforme | 2.36e-03 | 111 | 70 | 3 | C1621958 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CEGTGSGSRFQTVDS | 331 | P21860 | |
| GQCRNTSFFETEGCG | 641 | Q9H013 | |
| AFQFQCSSDSTNGTG | 511 | Q96KE9 | |
| CGFQGTEARAFASTG | 791 | Q5TGY3 | |
| ACGETLQDSTGNFSS | 321 | P13497 | |
| CVNGGTCRQTGDFTF | 191 | Q7Z3S9 | |
| SFNFLSNTGAASCQG | 776 | Q8HWS3 | |
| TLEGISSGGSFCNSG | 46 | Q7Z3Y9 | |
| LTNSFGFGGTNATLC | 441 | Q9NWU1 | |
| CNGNVSGGFDASTSQ | 91 | Q9Y6H3 | |
| GLCGNFNGDTTDDFT | 531 | Q6W4X9 | |
| VNGGTCRQTGDFTFE | 231 | P0DPK3 | |
| VNGGTCRQTGDFTFE | 231 | Q04721 | |
| CFNGGTCVDGINSFS | 996 | Q04721 | |
| GGSSFCSSGDSVIGQ | 641 | Q504Q3 | |
| GGSAGQSSVFQCFDV | 261 | P14902 | |
| SCFNGGTCVDGINSF | 991 | P46531 | |
| CDSINSDFGSESGGC | 11 | Q8TD19 | |
| QFDGGNCSSVGSLSY | 736 | O60486 | |
| SSSNVSQGFEGCLDA | 3901 | Q9NYQ8 | |
| DTSFRSENQFVGGGS | 306 | Q7Z5P9 | |
| QSTSKAAFGGGADCQ | 246 | P07202 | |
| CGTGDQGALFGNLST | 296 | P07202 | |
| IDGTFSSSGCLNGSF | 426 | Q5GLZ8 | |
| SSCFNGGTCVDGVNS | 931 | Q9UM47 | |
| FSSRSLNSFGGCLEG | 36 | Q8N1N4 | |
| FCQASGFGSSNTGSV | 1836 | P35658 | |
| GSSGPEFSCNSFLQE | 201 | P28356 | |
| SGFCVNGDVGFGISS | 756 | Q6IE36 | |
| VGTNEFTAEQCFGDG | 1166 | Q96F07 | |
| CVNGGTCRQTGDFTF | 191 | P0DPK4 | |
| TGFLCNFSTESNGFS | 121 | Q86VF5 | |
| SQTFGEGDQGEGCST | 3161 | Q6V1P9 | |
| DGDSSSAFQLGRFCG | 536 | O60494 | |
| ECGGDLQGSIGTFTS | 2451 | O60494 | |
| GGDNSSCKTVAGTFN | 746 | Q9P2N4 | |
| SGGFSVEETSCGDTG | 1011 | Q9Y2F5 | |
| FVKTGSSSGGDCNQD | 1806 | Q9Y2F5 | |
| GSFCKAGGTLENADS | 561 | P22460 | |
| GEVGQFQVDCSSAGS | 1176 | P21333 | |
| DSYSTCNVSSGFFGG | 26 | Q9NZC4 | |
| LGQNDTGFSCDGTAN | 391 | Q9H0C5 | |
| FSTIGAANGTCFTAG | 311 | P82251 | |
| ECENGGSCVNVFGSF | 4106 | Q8TDW7 | |
| FGENFASCQAGISSF | 191 | P13612 | |
| SDQSICAFQNSFLGG | 601 | P82279 | |
| GENQGQTFTCGSALS | 726 | P42658 | |
| TVLGQNDTGFSCDGS | 431 | Q9BX70 | |
| NDTGFSCDGSASTFR | 436 | Q9BX70 | |
| ECGSAVSFSGSSNFG | 201 | Q86VB7 | |
| EDSGIFQCFASNEGG | 451 | Q7Z5N4 | |
| NLFQTGSNVSFSCGG | 191 | Q9H4L5 | |
| SAQGQFSAGGCTFDD | 26 | Q15262 | |
| EDTVGLCGTFNGNTQ | 646 | Q6ZRI0 | |
| LCGTFNGNTQDDFLS | 651 | Q6ZRI0 | |
| QEQGTDGGAFASISC | 591 | Q6ZVC0 | |
| TQTCGGTDSTEGLFN | 271 | Q9NYV6 | |
| ISSNGEQCFSGGIDA | 541 | Q13033 | |
| FLSGCGRTFEGNAET | 256 | Q8N490 | |
| VCNVGGGADSVFSDT | 681 | Q9Y4F9 | |
| NFTCTQGGKDFTASS | 151 | O43361 | |
| QSSSFGGEGALETCS | 136 | Q9H2G4 | |
| NFGFGTDTGVTSSAD | 926 | Q6GYQ0 | |
| ATFICFSQQSGDGTF | 161 | Q2QL34 | |
| NTDFGGTLSTSVCFG | 1036 | Q12816 | |
| GDGFTQSNFDGCITS | 316 | Q5VYX0 | |
| FSVAASCGGGVDSSQ | 241 | Q96SI1 | |
| SCGGGVDSSQFSEYV | 246 | Q96SI1 | |
| FDDSGSFIVTCGSDG | 21 | O75717 | |
| VGFLSGGVDSCQGDS | 791 | Q9Y5Y6 | |
| FSEQLCSSFPGSGGS | 46 | Q12772 | |
| FAFGAQTSTTADQGA | 1171 | P49790 | |
| GAGESGGQDSTFECN | 26 | Q96GF1 | |
| CGSSFSRNGSEGALQ | 406 | P41587 | |
| GGNFLDSTNTGVNCV | 346 | Q9P272 | |
| FESAEGSQCGETFTQ | 6 | Q8N8L2 | |
| GRADCGFTSESYQQG | 126 | A0A5B9 | |
| FTYTGCGGNDNNFVS | 186 | P48307 | |
| GGVESALSCFSFNQD | 11 | Q5MNZ9 | |
| VQKSEFSCSGQGEAG | 256 | O75093 | |
| TIGGGDDSFTTFFCE | 41 | P68366 | |
| VTCQGGEGNSTFYVD | 416 | Q9UPR5 |